Status:
COMPLETED
Preliminary Study of Safety and Efficacy of Policosanol
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Dyslipidemia
HIV Infections
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Lay Language Summary: High cholesterol levels are common in persons with HIV infection. However, conventional cholesterol-lowering medications may have harmful side effects when given to HIV-infected ...
Detailed Description
As per Brief Summary
Eligibility Criteria
Inclusion
- CD4 count \> 250 Plasma HIV RNA \< 50,000 Currently receiving HAART age 18-60 total cholesterol between 200-240 or triglycerides between 150-400 or LDL cholesterol \> 160
Exclusion
- kidney or liver disease current use of lipid-lowering drugs pregnancy lactation
- \-
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00312923
Start Date
September 1 2005
End Date
September 1 2009
Last Update
July 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612